COMPASS Pathways H1 2023 net loss $52.5M; Phase 3 psilocybin trials on track

COMPASS Pathways plc

2023-Q2 EPS reported -$1.19

Net loss for H1 2023: $52.5M ($1.19 loss per share) vs $42.2M ($1.00) in H1 2022.
Cash $148.2M; secured $50M term loan from Hercules Capital, $28.1M drawn.
COMP360 Phase 3 TRD trials on track; topline data expected summer 2024 (COMP 005) and mid-2025 (COMP 006).
AMA accepted CPT III code for in-person psychedelic therapy support, aligning with COMP360 requirements.
ATAI exercised demand registration rights for 7,935,663 shares; filing required within 45 days.

item 2.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

COMPASS Pathways plc reported six months ended June 30, 2023 results: net income $52.5 million, or $1.19 loss per share, EPS $1.19 loss per share. Guidance reaffirmed.

Period: six months ended June 30, 2023
Net income: $52.5 million, or $1.19 loss per share
EPS: $1.19 loss per share
Guidance: reaffirmed
Result: reported results

Exact text from the filing

Net loss for the six months ended 30 June 2023 was $52.5 million, or $1.19 loss per share (including non-cash share-based compensation expense of $8.6 million)

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

COMPASS Pathways plc reported second quarter 2023 results: net income $28.3 million, or $0.62 loss per share, EPS $0.62 loss per share. Guidance reaffirmed.

Period: second quarter 2023
Net income: $28.3 million, or $0.62 loss per share
EPS: $0.62 loss per share
Guidance: reaffirmed
Result: reported results

Exact text from the filing

Net loss for the three months ended 30 June 2023 was $28.3 million, or $0.62 loss per share (including non-cash share-based compensation expense of $4.6 million)

View on SEC.gov

59 earnings releases filed in the last 30 days. Browse all earnings releases →

COMPASS Pathways plc filing history →

Source: SEC EDGAR

accession 0001628280-23-026987

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.